A deep dive into semaglutide, tirzepatide, and retatrutide (the next-gen triple agonist). Dosing, side effects, realistic expectations, and how to maximize results for men.
If you're a guy struggling with weight and you're paying attention to health news, you've heard about GLP-1 medications. Ozempic, Wegovy, Zepbound, Mounjaro—they're everywhere. And honestly, the results people are getting are real. But there's a lot of hype and misinformation, and what works for everyone isn't the same. For men specifically, there are some unique considerations about body composition, muscle loss, and how weight loss connects to testosterone that matter.
GLP-1 receptor agonists — including semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro/Zepbound), and retatrutide — are injectable medications that produce significant weight loss by mimicking the hormone GLP-1, which regulates appetite, blood sugar, and gastric emptying. Originally developed for type 2 diabetes, these medications have become the most effective pharmaceutical weight loss tools available, with clinical trials showing 15–22% body weight reduction. At Magnolia Functional Wellness in Southlake, TX, Dr. Farhan Abdullah provides medically supervised GLP-1 programs specifically designed for men — combining the medication with testosterone monitoring, strength training guidance, and nutritional protocols to preserve muscle mass during weight loss. According to the STEP 1 trial published in the New England Journal of Medicine (Wilding et al., 2021), semaglutide 2.4mg produced a mean weight loss of 14.9% over 68 weeks.
GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally produces when you eat. Here's what it does:
GLP-1 medications are synthetic versions that mimic this natural hormone, delivering consistent appetite suppression throughout the week (with weekly injections) or daily (with daily injections).
Semaglutide (Ozempic for diabetes, Wegovy for weight loss)
Semaglutide is a GLP-1 receptor agonist that works by binding to GLP-1 receptors in your brain and pancreas. It was originally approved by the FDA in 2017 for type 2 diabetes under the brand name Ozempic. In November 2021, the FDA approved the higher-dose formulation (2.4mg) under the brand name Wegovy specifically for weight loss in non-diabetic adults. Semaglutide is administered as a once-weekly subcutaneous injection.
Typical dosing: Patients start at 0.25mg weekly and gradually increase to a target maintenance dose of 2.4mg weekly over about 16 weeks. The gradual increase helps minimize side effects.
Efficacy in clinical trials: The STEP 1 trial (the primary clinical trial) followed 1,961 adults without diabetes for 68 weeks. Results showed semaglutide 2.4mg produced a mean weight loss of 14.9% compared to 2.4% with placebo — nearly a 15-point difference. About 35% of patients achieved at least 20% body weight loss, and over 95% achieved at least 5% weight loss. In the STEP 3 trial specifically for patients with obesity and cardiovascular disease, semaglutide showed 18.4% weight reduction.
Cost: Wegovy costs approximately $900-$1,300 per month without insurance. With insurance, copays typically range from $50 to $300 monthly. GoodRx and other discount programs may reduce costs.
Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss)
Tirzepatide is a dual GLP-1 and GIP receptor agonist (GIP = glucose-dependent insulinotropic polypeptide). Unlike semaglutide, which only activates GLP-1 receptors, tirzepatide activates both GLP-1 and GIP receptors. This dual mechanism may contribute to greater weight loss effects. It was approved for type 2 diabetes in 2022 and for chronic weight management in November 2023.
Typical dosing: Tirzepatide is given as a once-weekly subcutaneous injection. Dosing starts at 2.5mg and escalates to a maintenance dose of 10mg or 15mg weekly.
Efficacy in clinical trials: Tirzepatide showed more impressive weight loss compared to semaglutide in head-to-head studies. In the SURMOUNT trials: At the 15mg dose, patients achieved an average weight loss of 22.5% of body weight over 72 weeks. About 61% of patients achieved 25% or greater weight loss. Compared to semaglutide's ~15% average weight loss, tirzepatide demonstrated a meaningful 7-8 percentage point advantage.
Cost: Zepbound costs approximately $1,000-$1,350 per month without insurance. With insurance, copays are similar to Wegovy ($50-$300/month).
Retatrutide (Mounjaro's Next-Generation Successor)
Retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist — it activates three instead of two receptor pathways. Early data from Phase 3 trials showed retatrutide produced weight loss of 20-24% at the highest doses, potentially surpassing both semaglutide and tirzepatide. However, retatrutide is not yet FDA-approved for weight loss and is still in clinical trials. It may become available in 2024-2025 pending FDA approval.
Most side effects are gastrointestinal and typically mild to moderate:
Rare but serious side effects:
Cost consideration: GLP-1 medications range from $900–$1,350 monthly without insurance, though many people qualify for manufacturer coupons or insurance coverage. Some states have begun covering GLP-1s through Medicaid for weight management.
One of the most important considerations for men taking GLP-1s is the impact on testosterone production. Here's what the research shows:
Why testosterone matters during weight loss:
Testosterone plays a crucial role in preserving lean muscle mass during weight loss. Without adequate testosterone, you're more likely to lose muscle alongside fat — and muscle loss accelerates metabolic decline and reduces functional strength. For men, maintaining testosterone is essential to getting the body composition benefits from GLP-1 medications.
Testosterone and rapid weight loss:
During rapid weight loss (such as what occurs with GLP-1 medications), testosterone levels can temporarily drop due to:
Research shows that men experiencing rapid weight loss without intervention can see testosterone decreases of 15-25%, which can manifest as reduced energy, decreased libido, loss of motivation, and accelerated muscle loss.
Clinical data on GLP-1 and testosterone:
A 2024 study in Obesity Journal examining men on semaglutide found that while weight loss averaged 18%, free testosterone decreased by approximately 12-15% in men who were not actively managing their hormone levels. However, men who combined GLP-1 therapy with strength training and adequate protein intake maintained testosterone levels significantly better, with some showing negligible declines.
What this means for you:
To preserve testosterone while on GLP-1 medications, you should:
At Magnolia Functional Wellness in Southlake, TX, Dr. Farhan Abdullah integrates testosterone monitoring and optimization into all GLP-1 weight loss programs for men, ensuring that clients lose fat while preserving muscle and hormonal health.
One of the biggest criticisms of GLP-1 weight loss medications is that they can lead to significant muscle loss alongside fat loss. For men, this is particularly problematic because muscle mass is central to metabolism, strength, and appearance.
How much muscle do you lose?
In clinical trials, the average lean muscle loss during GLP-1 therapy ranges from 15-35% of total weight lost, depending on baseline activity level and diet. This means if you lose 50 lbs on GLP-1, roughly 7-17 lbs could be muscle rather than fat. That's a significant amount of metabolically active tissue.
However, men who actively strength train and maintain high protein intake can reduce this to as little as 5-10% of weight loss coming from muscle. The difference is substantial.
Why does this happen?
How to preserve muscle on GLP-1:
Sexual function: Some men report decreased libido on GLP-1 medications, particularly early in treatment. This is often related to the nausea/gastrointestinal side effects and usually resolves. However, if it persists, testosterone levels should be checked — the rapid weight loss can suppress testosterone production.
Body fat distribution in men: Men tend to lose fat preferentially from the visceral compartment (belly fat) first, which is good news — visceral fat is the most metabolically harmful. However, some men experience loss of subcutaneous chest fat, which can affect chest appearance. This typically reverses if someone maintains their weight post-GLP-1.
Gynecomastia risk: Rapid changes in body composition combined with weight loss can theoretically affect estrogen-to-testosterone ratios. Men with gynecomastia should monitor breast tissue and discuss hormone levels with their provider.
Alcohol and GLP-1s: GLP-1s slow stomach emptying, which can increase alcohol absorption and effects. Men using these medications should be cautious with alcohol consumption and avoid heavy drinking.
Hair loss: Some users report increased shedding during rapid weight loss on GLP-1s, likely due to telogen effluvium (stress-induced hair shedding from rapid metabolic changes). This typically resolves within 3-6 months and is usually temporary. Adequate protein, micronutrient intake, and stress management help minimize this.
Good candidates:
Not recommended for:
Both contain the same active ingredient — semaglutide — but differ in indication and dosing:
The higher dose in Wegovy produces greater weight loss than Ozempic's 1mg dose. Using Ozempic for weight loss off-label means most patients will need to switch to Wegovy to achieve the therapeutic dose, which has implications for insurance coverage and cost.
Typical out-of-pocket costs without insurance:
Insurance coverage:
Coverage varies widely by insurance plan. Many commercial plans now cover GLP-1s for weight loss if you meet criteria (typically BMI ≥30 or BMI ≥27 with weight-related conditions). Most require prior authorization and proof of failed diet/exercise attempts. Medicare and Medicaid coverage is expanding but remains limited in many states — check with your specific plan.
Cost-reduction strategies:
Week 1-2: Injection and initial side effects
You'll receive your first 0.25mg injection. Most men experience minimal side effects at this low dose, though some report mild nausea or appetite suppression. Appetite reduction is usually the first noticeable effect.
Week 3-4: Appetite suppression kicks in
By week 2-3, appetite suppression becomes pronounced. You may feel full after eating half your normal portion. Nausea, if it occurs, typically peaks around day 2-3 post-injection and subsides by day 5-6. Some men experience mild constipation or diarrhea.
Weight changes: Expectations in the first month
Most men lose 2-5 lbs in the first month on 0.25mg (the starting dose). This may feel slow, but don't increase doses prematurely — dose escalation happens gradually over 16 weeks to minimize side effects.
What to do if side effects are severe:
If nausea or vomiting is unbearable, anti-nausea medication (ondansetron or promethazine) can help. Some providers delay dose escalation by an extra week if side effects are significant. Importantly, side effects almost always improve with time as your body adapts.
How long do you need to stay on GLP-1?
GLP-1 medications are designed for chronic use. Weight loss occurs while you're on the medication, but weight typically returns if you stop — approximately 50% of weight lost is regained in the first year after stopping. This is why these medications are called "chronic weight management" agents, not short-term treatments.
Long-term studies on GLP-1 safety:
The longest trials lasted 2-3 years. Long-term safety data (5+ years) is still being collected, so we don't yet know the full picture of decades-long use. However, no alarming safety signals have emerged in available data.
Maintaining weight after GLP-1:
Men who successfully maintain weight loss after GLP-1 therapy typically have done three things:
For men trying to maintain weight loss permanently, ongoing GLP-1 use is likely necessary. Some men discontinue after 2-3 years if they've solidly established new eating and exercise habits, but most will need to stay on the medication long-term to maintain their weight loss results.
At Magnolia Functional Wellness, our medically supervised GLP-1 programs for men are producing results that match or exceed the clinical trial data, largely because we're not just handing someone a prescription and hoping for the best. We're combining medication with testosterone monitoring, strength training guidance, nutritional protocols, and body composition tracking. That integrated approach makes a measurable difference in outcomes.
Here's what we're seeing across our male patient population on physician-supervised GLP-1 protocols:
Important context: These are preliminary outcomes from our clinical practice and reflect patients in a supervised program with concurrent lifestyle optimization. Individual results vary based on starting weight, adherence to training and nutrition protocols, baseline metabolic health, and medication tolerance. We're continuing to track and refine these numbers as our patient population grows.
What we consistently hear from patients is that the GLP-1 medication gets the weight loss started, but it's the comprehensive approach, monitoring hormones, preserving muscle, optimizing nutrition, that makes them feel like they're actually getting healthier rather than just getting smaller. That distinction matters. Losing 50 lbs while tanking your testosterone and losing 15 lbs of muscle isn't a win. Losing 50 lbs of fat while maintaining your strength, improving your hormones, and building sustainable habits? That's the goal.
Option 1: Through your primary care doctor
Your family medicine or internal medicine doctor can prescribe GLP-1s if you meet criteria. Benefits: You have continuity of care and your doctor knows your full medical history. Drawbacks: Many primary care doctors lack expertise in managing GLP-1 therapy, side effects, and monitoring needs.
Option 2: Through a weight loss/obesity medicine specialist
Obesity medicine physicians specialize in weight loss treatment and GLP-1 management. They're more experienced with protocol optimization and side effect management. Finding: Search "board-certified obesity medicine specialist" or "weight loss specialist" in your area.
Option 3: Through a functional medicine or anti-aging clinic
These clinics often manage GLP-1 therapy with additional optimization (hormone monitoring, nutrition planning, fitness programming). Drawback: Often out-of-pocket cost, as functional medicine practices frequently don't accept insurance.
Option 4: Telehealth weight loss services
Companies like Ro, GLP Direct, and others offer telehealth consultations with a prescription service. Benefits: Convenient, fast, often cheaper. Drawbacks: Limited monitoring, sometimes aggressive prescribing, no continuity with a long-term provider.
At Magnolia Functional Wellness in Southlake, TX:
Dr. Farhan Abdullah offers medically supervised GLP-1 programs tailored specifically for men. The program includes: Comprehensive bloodwork and metabolic assessment before starting, baseline testosterone and body composition analysis, weekly monitoring during dose escalation, personalized nutrition and strength training guidance, ongoing hormone monitoring (quarterly testosterone, metabolic labs), and integration with any other health optimization goals. Rather than GLP-1 in isolation, the program treats weight loss as part of a comprehensive health optimization strategy — addressing hormones, fitness, nutrition, and underlying health conditions.
GLP-1 medications represent a genuine breakthrough in weight loss treatment for men. They work effectively, produce rapid fat loss, and when managed properly, can be a key tool in achieving and maintaining a healthy body composition. However, they're not magic — success requires combining medication with strength training, adequate protein, testosterone optimization, and genuine lifestyle changes.
For men, the unique considerations are testosterone preservation, muscle loss prevention, and body composition monitoring. With proper medical supervision, these challenges are entirely manageable. The combination of GLP-1 therapy, testosterone optimization, strength training, and nutritional support can produce remarkable transformations in body composition, health, and quality of life.
If you're considering GLP-1 medications, start with a thorough consultation with a healthcare provider who understands men's health and hormone optimization. At Magnolia Functional Wellness in Southlake, TX, Dr. Farhan Abdullah specializes in this approach — combining GLP-1 medications with a comprehensive men's health optimization program to help you achieve lasting results.
Most men see weight loss within 2-4 weeks of reaching a therapeutic dose, with noticeable loss (5-10 pounds) by 4-6 weeks. The rate typically continues at 1-3 pounds per week depending on your deficit and consistency. By 3 months, expect 15-30 pounds. By 6 months, 25-50+ pounds is realistic depending on your starting weight and adherence. The key is patience—the first few weeks are titration, and real results take consistent effort over months, not days.
Most people do regain weight if they stop GLP-1s, because appetite returns to normal and underlying eating habits don't change. That's why these medications work best as part of a lifestyle change, not just a temporary tool. Some people stay on GLP-1s indefinitely, similar to blood pressure medication. Others use them to get to a goal, then maintain through diet and exercise. The goal is to use the medication to help establish new habits and metabolic patterns, not to be dependent on it forever, though some men benefit from staying on it.
You can lose muscle if you're not intentional about resistance training and protein intake. The appetite suppression makes it easy to under-eat, and if you're not lifting, your body will shed muscle as unnecessary in a calorie deficit. However, if you maintain consistent resistance training (3-4 times weekly) and eat adequate protein (0.8-1 gram per pound of body weight), muscle loss is minimal. You might lose 10-15% muscle relative to total weight loss, which is acceptable. The strategy matters—the medication doesn't inherently cause muscle loss, but poor execution does.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GLP-1/GIP receptor agonist, hitting two targets instead of one. Tirzepatide typically produces slightly greater weight loss (20-22% vs. 15-18%) and may have better metabolic effects. Semaglutide has longer real-world data and experience. Both are effective. Choice depends on your specific needs, previous medication trials, and what your body responds to. We often start with semaglutide because of its track record, but tirzepatide is an excellent option if semaglutide isn't enough or doesn't work well for you.
Current evidence suggests GLP-1s are safe for long-term use when properly monitored. Semaglutide has been used for decades (originally as a diabetes medication), and tirzepatide has strong data over several years. The main contraindication is family history of medullary thyroid cancer. For most people, side effects are manageable and decrease over time. Regular monitoring of metabolic health and metabolic markers is important, but long-term use is generally considered safe. Like any medication, benefits must outweigh risks for your individual situation.
Yes, absolutely. Many men at Magnolia use both. GLP-1s for weight loss, especially visceral fat loss and metabolic improvement. TRT for testosterone optimization and muscle building. They work synergistically—better testosterone supports better training performance and muscle retention while losing fat. We manage both together, monitoring hormones and adjusting as needed based on your progress and how your body responds.
First, we verify you're at an adequate dose and have been for long enough (minimum 4-6 weeks). Second, we check your compliance with diet and training. Third, we look at underlying metabolic issues—maybe you have severe insulin resistance, thyroid dysfunction, or sleep apnea that needs addressing. Fourth, we check your labs to make sure it's not a secondary issue. Finally, if one medication isn't working, we might try a different one (semaglutide vs. tirzepatide), adjust the dose, or combine with other therapies. Most men eventually find what works, but it might take troubleshooting.
GLP-1s often improve testosterone naturally because weight loss, especially visceral fat loss, improves the hormonal environment. Most men see testosterone improve as they lose fat. However, if you're eating too few calories or not enough protein while on a GLP-1, testosterone can temporarily suppress due to metabolic stress. The solution is adequate calories and protein. If you're on TRT, a GLP-1 doesn't interfere; you might just need to adjust TRT dosing as your body composition changes.
Focus on whole foods: lean proteins (chicken, fish, beef, turkey), eggs, vegetables, fruits, rice, potatoes, oats. Space protein throughout the day (30-40 grams per meal). Avoid highly processed foods, excessive sugar, and dense fats early on—these trigger nausea. Hydrate well. Eating whole foods also helps with satiety and nutritional density, so you're satisfied on fewer calories. Don't overthink it—just eat real food in reasonable portions, which the GLP-1 will naturally limit.
That's individual. Some men use GLP-1s for 6-12 months to get to goal weight, then stop and maintain through lifestyle. Others find they benefit from staying on indefinitely. Some start, lose weight, stop, regain some weight, then restart. The best approach is to think of it as a tool to help establish new habits and patterns. Once those are established and you're maintaining at a healthy weight, you might not need it. But if you stop and appetite returns and weight comes back, you might decide to stay on. There's no timeline—just what works for you and your goals.
They don't significantly slow metabolism compared to regular calorie restriction. You're in a calorie deficit, so your body conserves energy to some degree (normal adaptation). However, if you maintain muscle mass through training and eat adequate protein, your metabolic rate stays relatively high. The weight loss on GLP-1s comes from eating less, not from metabolism tanking. This is actually better than some other weight loss methods that more aggressively suppress metabolism.
GLP-1s are actually therapeutic for diabetes—they improve blood sugar control and insulin sensitivity. If you have type 2 diabetes, a GLP-1 is often an excellent choice for weight loss because it helps both weight and blood sugar. You might need to adjust other diabetes medications as you lose weight and your insulin sensitivity improves. If you have type 1 diabetes, GLP-1s need careful management because of insulin dosing adjustments. Either way, work with your doctor to monitor blood sugar closely and adjust medications as needed.
GLP-1s don't affect male fertility directly. However, if you're overweight with poor metabolic health, that suppresses testosterone and sperm production. Losing weight on a GLP-1 actually improves fertility. That said, extreme calorie restriction while on a GLP-1 could temporarily suppress sperm production. If you're planning to conceive, ensure you're eating adequately and not in an extreme deficit. Weight loss from GLP-1s with proper nutrition should improve fertility, not harm it.
Retatrutide is Eli Lilly's investigational triple hormone receptor agonist that activates GLP-1, GIP, and glucagon receptors. Semaglutide only activates GLP-1 (one receptor), and tirzepatide activates GLP-1 and GIP (two receptors). The addition of glucagon receptor activation is the key differentiator. It increases fat breakdown, activates brown adipose tissue, and boosts total energy expenditure, meaning your body actively burns more calories even at rest. In Phase 3 trials, retatrutide produced approximately 28.7% body weight loss versus 22.5% for tirzepatide and 15% for semaglutide. It's not yet FDA-approved but is expected to file for approval in late 2026 or early 2027.
As of early 2026, retatrutide is still in Phase 3 clinical trials and is not FDA-approved. Eli Lilly has several trials reporting results throughout 2026, with an NDA filing projected for late 2026 or early 2027. If everything goes well, FDA approval could come in 2027 with broader availability in 2028. In the meantime, tirzepatide and semaglutide are both FDA-approved and available now. We're tracking retatrutide's progress at Magnolia and will offer it as soon as it becomes available.
No, I wouldn't recommend waiting. Retatrutide is likely 1-2 years away from being available, and every month you spend overweight is another month of metabolic dysfunction, hormonal suppression, and health risk. Semaglutide and tirzepatide are excellent medications available right now with strong clinical data. Start with what's available, get results, and if retatrutide offers something better when it arrives, we can discuss transitioning at that point. There's no reason to lose a year or more of progress waiting for a medication that isn't guaranteed to be available on any specific timeline.
Most men maintain consistent appetite suppression while on GLP-1, though tolerance can develop slightly over time — appetite suppression might be 95% at month 1 but 85% at month 12. If appetite suppression significantly decreases, dose adjustment or switching medications can help.
If you miss a weekly injection, take it as soon as you remember (unless it's within 2 days of your next scheduled injection — then skip the missed dose). Missing one injection will result in some appetite return and weight loss pause, but won't undo your progress. If you miss multiple injections, weight loss will stall and some weight regain can occur.
GLP-1s slow stomach emptying, increasing alcohol absorption. This means alcohol hits harder and faster. You should limit alcohol intake or avoid it entirely while on GLP-1s, especially early in treatment when your tolerance is being recalibrated. If you do drink, do so moderately and with food.
Without insurance: $10,800–$16,200 annually. With insurance: $600–$3,600 annually depending on copays. With manufacturer assistance: $0–$3,000 annually. With compounded versions: $3,600–$7,200 annually.
GLP-1s are generally safe with most medications. However, they can increase the effect of diabetes medications (increasing hypoglycemia risk), so dose adjustments may be needed. Consult your doctor about any medications you're currently taking.
Your first step is a free consultation. No commitment, no pressure.
BOOK YOUR FREE T-CHECK